Literature DB >> 2296028

N-phenyl-2-pyridinecarbothioamides as gastric mucosal protectants.

W A Kinney1, N E Lee, R M Blank, C A Demerson, C S Sarnella, N T Scherer, G N Mir, L E Borella, J F DiJoseph, C Wells.   

Abstract

A series of substituted 2-pyridinecarbothioamides was synthesized and evaluated for gastric mucosal protectant activity in the rat. Out of this investigation N-(3,5-difluorophenyl)-2- pyridinecarbothioamide (23, AY-31,574) was identified. This compound was much more potent than sucralfate and ranitidine against ethanol-induced lesions. Compound 23 was equipotent with ranitidine against gastric injury caused by stress. Unlike ranitidine, 23 was found to be devoid of antisecretory activity in the pylorus-ligated rat model, making it a selective mucosal protectant. Such a potent selective mucosal protectant may provide a novel clinical approach in treating ulcers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296028     DOI: 10.1021/jm00163a053

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide.

Authors:  Jahanzaib Arshad; Kelvin K H Tong; Sanam Movassaghi; Tilo Söhnel; Stephen M F Jamieson; Muhammad Hanif; Christian G Hartinger
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

2.  A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors.

Authors:  Debra Akin; S Keisin Wang; Pouran Habibzadegah-Tari; Brian Law; David Ostrov; Min Li; Xiao-Ming Yin; Jae-Sung Kim; Nicole Horenstein; William A Dunn
Journal:  Autophagy       Date:  2014-10-30       Impact factor: 16.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.